Posts Tagged ‘North Carolina’

Charter Medical Launches New High Yield Single-Use Cell Culture Bags

Charter Medical Launches New High Yield Single-Use Cell Culture Bags

Charter Medical, Ltd., a division of Lydall, Inc., (NYSE:LDL) today announced the launch of Bio-PakĀ® Cell Culture bags for biotech and pharmaceutical processing. These bags are designed to provide a stable cell culture environment to enhance cell growth and viability.... (Continue reading)

Tagged with:                                                                                     

Flanders Corporation Joins OTCQX

Flanders Corporation Joins OTCQX

Pink OTC Markets Inc. (Pink Sheets: PINK), the leading electronic inter-dealer quotation system, trading technology and financial information provider for Over-the-Counter (OTC) securities, today announced that Flanders Corporation (OTCQX: FLDR), a leading air filtration products manufacturer, is now trading on... (Continue reading)

2010 Facility of the Year Awards (FOYA) Winners Announced

2010 Facility of the Year Awards (FOYA) Winners Announced

Five pharmaceutical manufacturing facilities constructed in Singapore, Ireland, and the USA have been selected as Category Winners in the sixth annual Facility of the Year Awards (FOYA) program sponsored by ISPE, INTERPHEX, and Pharmaceutical Processing magazine. The winning companies and... (Continue reading)

cGMP Validation

Celebrating our 12th year in business, cGMP Validation specializes in the preparation and execution of validation IQ/OQ/PQ protocols, compliance documentation for equipment, utilities, processes, laboratory instruments, and computer systems. cGMP Validation has new and repeat clients across the United States, Puerto... (Continue reading)

Tagged with:                                                                                     

Novartis Inaugurates US Vaccine Manufacturing Facility in Holly Springs, North Carolina

Novartis Inaugurates US Vaccine Manufacturing Facility in Holly Springs, North Carolina

- Total investment of nearly USD 1 billion through a partnership between Novartis and the US Department of Health and Human Services - Inauguration marks important milestone in using modern biotechnologies for flu vaccine production to replace the 50 year-old egg-based... (Continue reading)

Tagged with: